MIGZYDE
DEAD

Serial Number

90668215

Owner

Cycle Pharmaceuticals Ltd.

Attorney

Mary Frances Love

Filing Date

Apr 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MIGZYDE Trademark

Serial Number: 90668215

MIGZYDE is a trademark filed by Cycle Pharmaceuticals Ltd. on April 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Cycle Pharmaceuticals Ltd. (23 trademarks)

The Broers Building,

Entity Type: 99

Trademark Details

Filing Date

April 23, 2021

Registration Date

Not Registered

Goods & Services

Education; Providing of training; Entertainment; Sporting and cultural activities; Publishing, reporting, and writing of texts; Publication of educational materials; support materials (non-downloadable), in-home training; support materials (non-downloadable) for in-home training, relating to the medical field; support materials (non-downloadable) for in-home training for patients with lysosomal storage disorders and lysosomal storage diseases; support materials (non-downloadable) for in-home training for patients with Gaucher Disease; Publishing, reporting, and writing of texts; Non-downloadable electronic publications; non-downloadable electronic publications for patients; non-downloadable electronic publications for patients with lysosomal storage disorders and lysosomal storage diseases; non-downloadable electronic publications for patients with Gaucher Disease; Support materials (non-downloadable) relating to the use and dosage of pre-filled syringe for subcutaneous injections; Support materials (non-downloadable) relating to the use and dosage of pre-filled syringe for subcutaneous injections in the treatment of acute attack of hereditary angioedema; in-home injection training; in-home training for use of syringes for subcutaneous injections; in-home training for use of syringes for subcutaneous injections in the treatment of acute attack of hereditary angioedema; information, advisory and consultancy services relating to the aforesaid

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; Apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; Recorded and downloadable media, computer software, blank digital or analogue recording and storage media; Mechanisms for coin-operated apparatus; Cash registers, calculating devices; Computers and computer peripheral devices; Diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; Fire-extinguishing apparatus; Recorded content; Media content; Downloadable educational materials relating to rare diseases; Downloadable educational materials relating to disorders of the metabolism and digestive system; Downloadable educational materials relating to lysosomal storage disorders and lysosomal storage diseases; Downloadable educational materials relating to Gaucher Disease; support materials (downloadable) relating to rare diseases; support materials (downloadable) relating to disorders of the metabolism and digestive system; support materials (downloadable) relating to lysosomal storage disorders and lysosomal storage diseases; support materials (downloadable) relating to Gaucher Disease; patient support materials (downloadable) relating to rare diseases; patient support materials (downloadable) relating to disorders of the metabolism and digestive system; patient support materials (downloadable) relating to lysosomal storage disorders and lysosomal storage diseases; patient support materials (downloadable) relating to Gaucher Disease; support material (downloadable) relating to the use of pre-filled syringe for subcutaneous injections; support material (downloadable) relating to the use of pre-filled syringe for subcutaneous injections in the treatment of acute attack of hereditary angioedema; Software; Application software; Computer software; Computer software for use in the medical field; software for use by patients in their treatment and management of lysosomal storage disorders and lysosomal storage diseases; software for use by patients in their treatment and management of Gaucher Disease; parts and fittings for all of the aforesaid goods

Transport; Packaging and storage of goods; Travel arrangement; Packaging of pharmaceuticals; storing of pharmaceuticals; shipment of pharmaceuticals; packaging of pharmaceuticals for patients with lysosomal storage disorders and lysosomal storage diseases; packaging of pharmaceuticals for patients with Gaucher Disease; storing of pharmaceuticals for patients with lysosomal storage disorders and lysosomal storage diseases; storing of pharmaceuticals for patients with Gaucher Disease; shipment of pharmaceuticals for patients with lysosomal storage disorders and lysosomal storage diseases; shipment of pharmaceuticals for patients with Gaucher Disease; Transportation and delivery of goods; Freight and cargo transportation and removal services; Transportation of pharmaceuticals; Transportation of pharmaceuticals for patients with lysosomal storage disorders and lysosomal storage diseases; Transportation of pharmaceuticals for patients Gaucher Disease; Shipment of pre-filled syringe for subcutaneous injections; Shipment of pre-filled syringe for subcutaneous injections in the treatment of acute attack of hereditary angioedema; pharmacy shipments; coordinating pharmacy shipments; information, advisory and consultancy services relating to the aforesaid

Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical agents for the treatment of Gaucher Disease; pharmaceutical agents for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of Gaucher Disease; pharmaceutical preparations for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of Gaucher Disease; pharmaceuticals for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of disorders of the metabolism and digestive system; veterinary preparations, namely, antioxidants; veterinary preparations, namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system; supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; supplements for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system; biological preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; biological preparations for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system; chemical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceuticals; drug delivery agents for use in the treatment of disorders of the metabolism and digestive system; drug delivery agents for use in the treatment of lysosomal storage disorders and lysosomal storage diseases; drug delivery agents for use in the treatment of Gaucher Disease; drugs and medicines for the treatment of disorders of the metabolism and digestive system; drugs and medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs and medicines for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system; drugs for the treatment of rare diseases, in particular for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for the treatment of disorders of the metabolism and digestive system; enzyme preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; enzyme preparations for the treatment of Gaucher Disease; medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems; medical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of Gaucher Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforesaid goods

Paper and cardboard; Printed matter; Bookbinding material; Photographs; Stationery and office requisites, except furniture; Adhesives for stationery or household purposes; Drawing materials and materials for artists; Paintbrushes; Instructional and teaching materials; Plastic sheets, films and bags for wrapping and packaging; Printers' type, printing blocks; Stationery and educational supplies; Educational equipment; Instructional and teaching material; Instructional and teaching material for patients with disorders of the metabolism and digestive system; Instructional and teaching material for patients with lysosomal storage disorders and lysosomal storage diseases; Instructional and teaching material for patients Gaucher Disease; Printed support materials; printed support materials for patients; printed materials to support patients with the treatment and management of lysosomal storage disorders and lysosomal storage diseases; printed support materials for patients with Gaucher Disease; instructional material relating to dosages and side effects of medications; instructional material relating to dosages and side effects of medications for lysosomal storage disorders and lysosomal storage diseases; instructional material relating to dosages and side effects of medications for Gaucher Disease; parts and fittings for all of the aforesaid goods

Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of Gaucher Disease; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of Gaucher Disease; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of Gaucher Disease; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of Gaucher Disease; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches

Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of Gaucher Disease; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to lysosomal storage disorders and lysosomal storage diseases; genetic testing in relation to Gaucher Disease; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to lysosomal storage disorders and lysosomal storage diseases; providing healthcare and medical information in relation to Gaucher Disease; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of lysosomal storage disorders and lysosomal storage diseases; providing medical product information and advisory services in relation to the treatment of Gaucher Disease; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to lysosomal storage disorders and lysosomal storage diseases; medical, pharmacological and pharmaceutical testing services in relation to Gaucher Disease; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of lysosomal storage disorders and lysosomal storage diseases; providing pharmaceutical information and advisory services in relation to the treatment of Gaucher Disease; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of lysosomal storage disorders and lysosomal storage diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of Gaucher Disease; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to lysosomal storage disorders and lysosomal storage diseases; providing news and information in the field of medicine in relation to Gaucher Disease; providing news and information in the field of medicine; providing news and information in the field of rare diseases

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 18, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 18, 2022 ABN2
ASSIGNED TO EXAMINER
Jul 18, 2022 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 5, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2021 NWOS
NEW APPLICATION ENTERED
Apr 27, 2021 NWAP